Effexor and Metastases to oesophagus - a phase IV clinical study of FDA data


Metastases to oesophagus is reported only by a few people who take Effexor.

The phase IV clinical study analyzes which people take Effexor and have Metastases to oesophagus. It is created by eHealthMe based on reports of 88,368 people who have side effects while taking Effexor from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2022

88,368 people reported to have side effects when taking Effexor.
Among them, 2 people (0.0%) have Metastases to oesophagus.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 95,239 Effexor users for its effectiveness, alternative drugs and more.

What is Metastases to oesophagus?

Metastases to oesophagus (cancer spreads to oesophagus) is found to be associated with 102 drugs and 40 conditions by eHealthMe.

Number of Effexor and Metastases to oesophagus reports submitted per year:

Could Effexor cause Metastases to oesophagus?

Gender of people who have Metastases to oesophagus when taking Effexor *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Metastases to oesophagus when taking Effexor *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 50 %
  • 60+: 0.0 %

Common drugs people take besides Effexor *:

  1. Zyprexa: 2 people, 100.00%
  2. Taxotere: 2 people, 100.00%
  3. Fentora: 2 people, 100.00%
  4. Avastin: 2 people, 100.00%
  5. Zometa: 2 people, 100.00%
  6. Anzemet: 1 person, 50.00%
  7. Ambien: 1 person, 50.00%
  8. Aranesp: 1 person, 50.00%
  9. Aredia: 1 person, 50.00%
  10. Herceptin: 1 person, 50.00%

Common side effects people have besides Metastases to oesophagus *:

  1. Wound Infection: 2 people, 100.00%
  2. Haematochezia (passage of stools containing blood): 2 people, 100.00%
  3. Dizziness: 2 people, 100.00%
  4. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 100.00%
  5. Exostosis (formation of new bone on the surface of a bone): 2 people, 100.00%
  6. Exposed Bone In Jaw: 2 people, 100.00%
  7. Facet Joint Syndrome (problem with movement of the facet joints of the spine): 2 people, 100.00%
  8. Fall: 2 people, 100.00%
  9. Fever: 2 people, 100.00%
  10. Gastritis (inflammation of stomach): 2 people, 100.00%

Common conditions people have *:

  1. Metastases To Bone (cancer spreads to bone): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and have Metastases to oesophagus?

Check whether Metastases to oesophagus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Metastases to oesophagus and when was it recovered:

Expand to all the drugs that have ingredients of venlafaxine hydrochloride:

Alternative drugs to, pros and cons of Effexor:

Common Effexor side effects:

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Metastases to oesophagus treatments and more:

COVID vaccines that are related to Metastases to oesophagus:

All the drugs that are associated with Metastases to oesophagus:

All the conditions that are associated with Metastases to oesophagus:

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Effexor) and Effexor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: